Design and Analysis of Cross-Over Trials, Second Edition

The first edition of Design and Analysis of Cross-Over Trials quickly became the standard reference on the subject and has remained so for more than 12 years. In that time, however, the use of cross-over trials has grown rapidly, particularly in the pharmaceutical arena, and researchers have made a number of advances in both the theory and methods applicable to these trials.Completely revised and updated, the long-awaited second edition of this classic text retains its predecessor's careful balance of theory and practice while incorporating new approaches, more data sets, and a broader scope. Enhancements in the second edition include:·A new chapter on bioequivalence·Recently developed methods for analyzing longitudinal continuous and categorical data·Real-world examples using the SAS system·A comprehensive catalog of designs, datasets, and SAS programs available on a companion Web site at www.crcpress.comThe authors' exposition gives a clear, unified account of the design and analysis of cross-over trials from a statistical perspective along with their methodological underpinnings. With SAS programs and a thorough treatment of design issues, Design and Analysis of Cross-Over Trials, Second Edition sets a new standard for texts in this area and undoubtedly will be of direct practical value for years to come.

---

Completely revised and updated, the second edition of this classic text retains its predecessor's careful balance of theory and practice while incorporating new approaches, more data sets, and a broader scope. Enhancements in this edition include a new chapter on bioequivalence, methods for analyzing longitudinal continuous and categorical data, extensive real-life examples, and SAS code that allows readers to implement the analyses described. With downloadable SAS programs, thorough treatment of design issues, and a comprehensive catalog of designs, this edition sets a new standard for texts in this area and will undoubtedly be of direct practical value for years to come.